AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2011
Feb 24, 2011
30339_dirs_2011-02-24_59184237-ec64-40b6-afc8-580a326379ea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-02-22
Reporting Person: Hunt Jeffrey C (VP Pharma Pckg Systems)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-22 | Common Stock | A | 631.0000 | $40.8500 | Acquired | 631.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-22 | Stock Option (Right to Buy) | $40.8500 | A | 22831.0000 | Acquired | 2021-02-22 | Common Stock (22831.0000) | Direct |
Footnotes
F1: Bonus and incentive shares granted on 02/22/2011.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27